JCI - Citations to Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons

Citations to this article

Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons

Hiroshi Yamamoto, … , Daniel J. Drucker, Joel K. Elmquist

Hiroshi Yamamoto, … , Daniel J. Drucker, Joel K. Elmquist

Published July 1, 2002
Citation Information: J Clin Invest. 2002;110(1):43-52. https://doi.org/10.1172/JCI15595.

View: Text | PDF

Total citations by year

Year:	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	Total
Citations:	1	12	5	10	15	10	13	3	12	12	12	21	11	11	13	13	10	11	4	3	4	2	3	211

Citation information

Citations to this article (211)

Title and authors	Publication	Year
Glucagon-like peptide-1 (GLP-1) links ingestion, homeostasis, and the heart Krieger JP, Daniels D, Lee S, Mastitskaya S, Langhans W	Comprehensive Physiology	2025
The GLP-1 journey: from discovery science to therapeutic impact. Drucker DJ	Journal of Clinical Investigation	2024
GLP-1 in the Hypothalamic Paraventricular Nucleus Promotes Sympathetic Activation and Hypertension. Xu XY, Wang JX, Chen JL, Dai M, Wang YM, Chen Q, Li YH, Zhu GQ, Chen AD	The Journal of neuroscience : the official journal of the Society for Neuroscience	2024
Cyclic Adenosine Monophosphate in Cardiac and Sympathoadrenal GLP-1 Receptor Signaling: Focus on Anti-Inflammatory Effects Lymperopoulos A, Borges JI, Stoicovy RA	Pharmaceutics	2024
From diabetes to diverse domains: the multifaceted roles of GLP-1 receptor agonists. Dave BP, Chorawala MR, Shah IV, Shah NN, Bhagat SU, Prajapati BG, Thakkar PC	Molecular Biology Reports	2024
Populations of Hindbrain Glucagon-Like Peptide 1 (GLP1) Neurons That Innervate the Hypothalamic PVH, Thalamic PVT, or Limbic Forebrain BST Have Axon Collaterals That Reach All Central Regions Innervated by GLP1 Neurons Randolph AB, Zheng H, Rinaman L	Journal of Neuroscience	2024
The role of glucagon-like peptide-1/GLP-1R and autophagy in diabetic cardiovascular disease. Guo Z	Pharmacological reports : PR	2024
Semaglutide treatment of hypothalamic obesity - a real-life data study. Svendstrup M, Rasmussen AK, Kistorp C, Klose M, Andreassen M	Pituitary	2024
Intestinal glucagon-like peptide-1: A new player associated with impaired counterregulatory responses to hypoglycaemia in type 1 diabetic mice Jin FX, Wang Y, Li MN, Li RJ, Guo JT	World Journal of Diabetes	2024
Glucagon-like peptide-1 increases heart rate by a direct action on the sinus node Lubberding AF, Veedfald S, Achter JS, Nissen SD, Soattin L, Sorrentino A, Vega ET, Linz B, Eggertsen CH, Mulvey J, Toräng S, Larsen SA, Nissen A, Petersen LG, Bilir SE, Bentzen BH, Rosenkilde MM, Hartmann B, Lilleør TN, Qazi S, Møller CH, Tfelt-Hansen J, Sattler SM, Jespersen T, Holst JJ, Lundby A	Cardiovascular Research	2024
Glucagon-like peptide-1 receptor agonist use is associated with reduced risk of out-of-hospital cardiac arrest in women with type 2 diabetes: A nationwide nested case-control study Eroglu TE, Coronel R, Folke F, Gislason G	Resuscitation Plus	2024
Incretin-based therapy: a new horizon in diabetes management Zarei M, Sahebi Vaighan N, Farjoo MH, Talebi S, Zarei M	Journal of Diabetes and Metabolic Disorders	2024
GLP-1 and Its Analogs: Does Sex Matter? Börchers S, Skibicka KP	Endocrinology	2024
Multifaceted Roles of GLP-1 and Its Analogs: A Review on Molecular Mechanisms with a Cardiotherapeutic Perspective Pandey S, Mangmool S, Parichatikanond W	Pharmaceuticals	2023
Glucagon-like Peptide-1 Receptor Activation Reduces Pulmonary Vein Arrhythmogenesis and Regulates Calcium Homeostasis Chan CS, Lin FJ, Chen YC, Lin YK, Higa S, Chen SA, Chen YJ	International journal of molecular sciences	2023
Exendin-4 promotes retinal ganglion cell survival and function by inhibiting calcium channels in experimental diabetes Wang YC, Wang L, Shao YQ, Weng SJ, Yang XL, Zhong YM	iScience	2023
The locus coeruleus contributes to the anorectic, nausea, and autonomic physiological effects of glucagon-like peptide-1 Fortin SM, Chen JC, Petticord MC, Ragozzino FJ, Peters JH, Hayes MR	Science Advances	2023
Treatment of hypothalamic obesity in people with hypothalamic injury: new drugs are on the horizon Roth CL, Zenno A	Frontiers in Endocrinology	2023
Integrative Hedonic and Homeostatic Food Intake Regulation by the Central Nervous System: Insights from Neuroimaging A Campos, J Port, A Acosta	Brain Sciences	2022
Signaling Mechanism for Modulation by GLP-1 and Exendin-4 of GABA Receptors on Rat Retinal Ganglion Cells Zhang T, Ruan HZ, Wang YC, Shao YQ, Zhou W, Weng SJ, Zhong YM	Neuroscience Bulletin	2022
Glucagon-Like Peptide 1 Receptor Agonists – Potential Game Changers in the Treatment of Glaucoma? Mouhammad ZA, Vohra R, Horwitz A, Thein AS, Rovelt J, Cvenkel B, Williams PA, Azuara-Blanco A, Kolko M	Frontiers in neuroscience	2022
GLP1R Attenuates Sympathetic Response to High Glucose via Carotid Body Inhibition Pauza AG, Thakkar P, Tasic T, Felippe I, Bishop P, Greenwood MP, Rysevaite-Kyguoliene K, Ast J, Broichhagen J, Hodson DJ, Salgado HC, Pauza DH, Japundzic-Zigon N, Paton JF, Murphy D	Circulation research	2022
Effect of race on cardiometabolic responses to once-weekly exenatide: insights from the Exenatide Study of Cardiovascular Event Lowering (EXSCEL) Davis TM, Giczewska A, Lokhnygina Y, Mentz RJ, Sattar N, Holman RR	Cardiovascular Diabetology	2022
Bolus Injection of Liraglutide Raises Plasma Glucose in Normal Rats by Activating Glucagon-like Peptide 1 Receptor in the Brain Hsu CC, Cheng JT, Hsu PH, Li Y, Cheng KC	Pharmaceuticals	2022
Effects of GLP-1 receptor agonists on arrhythmias and its subtypes in patients with type 2 diabetes: A systematic review and meta-analysis Wei J, Wang R, Ye H, Wang Y, Wang L, Zhang X	Frontiers in Endocrinology	2022
Beneficial Influence of Exendin-4 on Specific Organs and Mechanisms Favourable for the Elderly with Concomitant Obstructive Lung Diseases Figat M, Kardas G, Kuna P, Panek MG	Brain Sciences	2022
Glucagon-like Peptide-1 receptor Tie2+ cells are essential for the cardioprotective actions of liraglutide in mice with experimental myocardial infarction McLean BA, Wong CK, Kabir MG, Drucker DJ	Molecular Metabolism	2022
Effect of the Glucagon-Like Peptide-1 Receptor Agonists on Autonomic Function in Subjects with Diabetes: A Systematic Review and Meta-Analysis. Greco C, Santi D, Brigante G, Pacchioni C, Simoni M	Diabetes & Metabolism Journal	2022
The role of nucleus of the solitary tract glucagon‐like peptide‐1 and prolactin‐releasing peptide neurons in stress: anatomy, physiology and cellular interactions MK Holt, L Rinaman	British Journal of Pharmacology	2021
Brain GLP‐1 and the regulation of food intake: GLP‐1 action in the brain and its implications for GLP‐1 receptor agonists in obesity treatment S Trapp, DI Brierley	British Journal of Pharmacology	2021
Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease LL Baggio, DJ Drucker	Molecular Metabolism	2021
Irisin and Incretin Hormones: Similarities, Differences, and Implications in Type 2 Diabetes and Obesity N Marrano, G Biondi, A Borrelli, A Cignarelli, S Perrini, L Laviola, F Giorgino, A Natalicchio	Biomolecules	2021
Autonomic nervous system activity changes in patients with hypertension and overweight: role and therapeutic implications P Valensi	Cardiovascular Diabetology	2021
Role of Exendin-4 in Brain Insulin Resistance, Mitochondrial Function, and Neurite Outgrowth in Neurons under Palmitic Acid-Induced Oxidative Stress D Jo, G Yoon, J Song	Antioxidants	2021
An Overview of Similarities and Differences in Metabolic Actions and Effects of Central Nervous System Between Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) and Sodium Glucose Co-Transporter-2 Inhibitors (SGLT-2is) S Wen, T Nguyen, M Gong, X Yuan, C Wang, J Jin, L Zhou	Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy	2021
Effects of GLP-1 receptor agonist on changes in the gut bacterium and the underlying mechanisms S Kato, T Sato, H Fujita, M Kawatani, Y Yamada	Scientific Reports	2021
Activation of PPG neurons following acute stressors differentially involves hindbrain serotonin in male rats RM Leon, T Borner, LM Stein, NA Urrutia, BC Jonghe, HD Schmidt, MR Hayes	Neuropharmacology	2021
Exenatide once weekly over 2 years as a potential disease-modifying treatment for Parkinson’s disease: protocol for a multicentre, randomised, double blind, parallel group, placebo controlled, phase 3 trial: The ‘Exenatide-PD3’ study N Vijiaratnam, C Girges, G Auld, M Chau, K Maclagan, A King, S Skene, K Chowdhury, S Hibbert, H Morris, P Limousin, D Athauda, CB Carroll, MT Hu, M Silverdale, GW Duncan, R Chaudhuri, C Lo, SD Din, AJ Yarnall, L Rochester, R Gibson, J Dickson, R Hunter, V Libri, T Foltynie	BMJ Open	2021
Oral GLP-1 analogue: perspectives and impact on atherosclerosis in type 2 diabetic patients JF Saraiva, D Franco	Cardiovascular Diabetology	2021
How glucagon-like peptide 1 receptor agonists work CR Andreasen, A Andersen, FK Knop, T Vilsbøll	Endocrine Connections	2021
Effects of Liraglutide on Left Ventricular Function: A Meta-Analysis of Randomized, Placebo-Controlled Trials Zhong Z, Chen K, Zhao Y, Xia S	International Journal of Endocrinology	2021
Role of Renal Sympathetic Nerves in GLP‐1 (Glucagon‐Like Peptide‐1) Receptor Agonist Exendin‐4‐Mediated Diuresis and Natriuresis in Diet‐Induced Obese Rats Liu X, Patel KP, Zheng H	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease	2021
The Effects of Glucagon-Like Peptide-1 Receptor Agonists and Dipeptydilpeptidase-4 Inhibitors on Blood Pressure and Cardiovascular Complications in Diabetes. Yaribeygi H, Farrokhi FR, Abdalla MA, Sathyapalan T, Banach M, Jamialahmadi T, Sahebkar A	Journal of Diabetes Research	2021
PPG neurons in the nucleus of the solitary tract modulate heart rate but do not mediate GLP-1 receptor agonist-induced tachycardia in mice MK Holt, DR Cook, DI Brierley, JE Richards, F Reimann, AV Gourine, N Marina, S Trapp	Molecular Metabolism	2020
Revisiting the Complexity of GLP-1 Action from Sites of Synthesis to Receptor Activation BA McLean, CK Wong, JE Campbell, DJ Hodson, S Trapp, DJ Drucker	Endocrine reviews	2020
Glucagon-Like Peptide-1 (GLP-1) in the Integration of Neural and Endocrine Responses to Stress Y Diz-Chaves, S Herrera-Pérez, LC González-Matías, JA Lamas, F Mallo	Nutrients	2020
Effects of Glucagon-like Peptide-1 on the Reproductive Axis in Healthy Men C Izzi-Engbeaya, S Jones, Y Crustna, PC Machenahalli, D Papadopoulou, M Modi, C Panayi, J Starikova, PC Eng, M Phylactou, E Mills, L Yang, R Ratnasabapathy, M Sykes, I Plumptre, B Coumbe, VC Wing, E Pacuszka, P Bech, J Minnion, G Tharakan, T Tan, J Veldhuis, A Abbara, AN Comninos, WS Dhillo	The Journal of clinical endocrinology and metabolism	2020
GLP-1 mediated diuresis and natriuresis are blunted in heart failure and restored by selective afferent renal denervation K Katsurada, SS Nandi, H Zheng, X Liu, NM Sharma, KP Patel	Cardiovascular Diabetology	2020
GABA neurons in the nucleus tractus solitarius express GLP-1 receptors and mediate anorectic effects of liraglutide in rats SM Fortin, RK Lipsky, R Lhamo, J Chen, E Kim, T Borner, HD Schmidt, MR Hayes	Science Translational Medicine	2020
Cacao polyphenols regulate the circadian clock gene expression and through glucagon-like peptide-1 secretion K Hironao, Y Mitsuhashi, S Huang, H Oike, H Ashida, Y Yamashita	Journal of Clinical Biochemistry and Nutrition	2020
GLP-1 Receptor Signaling Differentially Modifies the Outcomes of Sterile vs Viral Pulmonary Inflammation in Male Mice T Sato, T Shimizu, H Fujita, Y Imai, DJ Drucker, Y Seino, Y Yamada	Endocrinology	2020
Exendin-4 inhibits atrial arrhythmogenesis in a model of myocardial infarction-induced heart failure via the GLP-1 receptor signaling pathway Chen J, Xu S, Wang L, Zhou W, Li P, Deng N, Tang Q, Li Y, Wu L, Chen J, Li W	Experimental and therapeutic medicine	2020
Evidence for Relationship Between Early Dumping and Postprandial Hypoglycemia After Roux-en-Y Gastric Bypass. Øhrstrøm CC, Worm D, Kielgast UL, Holst JJ, Hansen DL	Obesity surgery	2020
The Discovery and Development of Liraglutide and Semaglutide LB Knudsen, J Lau	Frontiers in Endocrinology	2019
Glucagon-like peptide 1 (GLP-1) TD Müller, B Finan, SR Bloom, D D'Alessio, DJ Drucker, PR Flatt, A Fritsche, F Gribble, HJ Grill, JF Habener, JJ Holst, W Langhans, JJ Meier, MA Nauck, D Perez-Tilve, A Pocai, F Reimann, DA Sandoval, TW Schwartz, RJ Seeley, K Stemmer, M Tang-Christensen, SC Woods, RD DiMarchi, MH Tschöp	Molecular Metabolism	2019
Synaptic Inputs to the Mouse Dorsal Vagal Complex and Its Resident Preproglucagon Neurons MK Holt, LE Pomeranz, KT Beier, F Reimann, FM Gribble, L Rinaman	The Journal of neuroscience : the official journal of the Society for Neuroscience	2019
Heart rate variability in type 2 diabetic subjects randomized to liraglutide or glimepiride treatment, both in combination with metformin: A randomized, open, parallel‐group study T Nyström, I SantosPardo, X Fang, Y Cao, F Hedberg, J Jendle		2019
Exendin-4 Exacerbates Burn-Induced Morbidity in Mice by Activation of the Sympathetic Nervous System XJ Ji, JW Hao, GL Li, N Dong, XQ Wang, M Zhou, QH Zhang, YM Yao	Mediators of Inflammation	2019
Update on the Impact, Diagnosis and Management of Cardiovascular Autonomic Neuropathy in Diabetes: What Is Defined, What Is New, and What Is Unmet V Spallone	Diabetes & Metabolism Journal	2019
DPP-4 Inhibitors as Potential Candidates for Antihypertensive Therapy: Improving Vascular Inflammation and Assisting the Action of Traditional Antihypertensive Drugs J Zhang, Q Chen, J Zhong, C Liu, B Zheng, Q Gong	Frontiers in immunology	2019
Persistently Elevated Glucagon-Like Peptide-1 Levels among Critically Ill Surgical Patients after Sepsis and Development of Chronic Critical Illness and Dismal Long-Term Outcomes SC Brakenridge, FA Moore, NR Mercier, M Cox, Q Wu, LL Moldawer, AM Mohr, PA Efron, RS Smith	Journal of the American College of Surgeons	2019
Central Glucagon-like Peptide-1 Receptor Signaling via Brainstem Catecholamine Neurons Counteracts Hypertension in Spontaneously Hypertensive Rats K Katsurada, M Nakata, T Saito, B Zhang, Y Maejima, SS Nandi, NM Sharma, KP Patel, K Kario, T Yada	Scientific Reports	2019
Effect of GLP-1 Receptor Agonists in the Cardiometabolic Complications in a Rat Model of Postmenopausal PCOS ED Fernandez, AM Huffman, M Syed, DG Romero, LL Cardozo	Endocrinology	2019
Does glucagon-like peptide-1 induce diuresis and natriuresis by modulating afferent renal nerve activity? K Katsurada, SS Nandi, NM Sharma, H Zheng, X Liu, KP Patel	American journal of physiology. Renal physiology	2019
Liraglutide treatment reduced interleukin-6 in adults with type 1 diabetes but did not improve established autonomic or polyneuropathy. Brock C, Hansen CS, Karmisholt J, Møller HJ, Juhl A, Farmer AD, Drewes AM, Riahi S, Lervang HH, Jakobsen PE, Brock B	British Journal of Clinical Pharmacology	2019
Effect of Liraglutide on Cardiovascular Function and Myocardial Tissue Characteristics in Type 2 Diabetes Patients of South Asian Descent Living in the Netherlands: A Double‐Blind, Randomized, Placebo‐Controlled Trial Paiman EH, van Eyk HJ, van Aalst MM, Bizino MB, van der Geest RJ, Westenberg JJ, Geelhoed\u2010Duijvestijn PH, Kharagjitsingh AV, Rensen PC, Smit JW, Jazet IM, Lamb HJ	Journal of Magnetic Resonance Imaging	2019
Liraglutide Modulates Appetite and Body Weight Via GLP-1R-Expressing Glutamatergic Neurons JM Adams, H Pei, DA Sandoval, RJ Seeley, RB Chang, SD Liberles, DP Olson	Diabetes	2018
Preproglucagon Neurons in the Nucleus of the Solitary Tract Are the Main Source of Brain GLP-1, Mediate Stress-Induced Hypophagia, and Limit Unusually Large Intakes of Food MK Holt, JE Richards, DR Cook, DI Brierley, DL Williams, F Reimann, FM Gribble, S Trapp	Diabetes	2018
Modulation of Cardiac Ventricular Excitability by GLP-1 (Glucagon-Like Peptide-1) R Ang, S Mastitskaya, PS Hosford, M Basalay, M Specterman, Q Aziz, Y Li, M Orini, P Taggart, PD Lambiase, A Gourine, A Tinker, AV Gourine	Circulation. Arrhythmia and electrophysiology	2018
Mouse Gcg Neuron Activation Reduces Food Intake and Body Weight Ronald Gaykema, brandon newmyer, matteo ottolini, Vidisha Raje, Daniel M. Warthen, Philip Lambeth, Maria Niccum, Ting Yao, yiru huang, Ira Schulman, Thurl Harris, manoj patel, kevin williams, Michael M. Scott	Journal of Clinical Investigation	2017
Effects of meal and incretins in the regulation of splanchnic blood flow J Koffert, H Honka, J Teuho, S Kauhanen, S Hurme, R Parkkola, V Oikonen, A Mari, A Lindqvist, N Wierup, L Groop, P Nuutila	Endocrine Connections	2017
Serotonergic modulation of the activity of GLP-1 producing neurons in the nucleus of the solitary tract in mouse MK Holt, IJ Llewellyn-Smith, F Reimann, FM Gribble, S Trapp	Molecular Metabolism	2017
Central Nervous System GLP-1 Receptors Regulate Islet Hormone Secretion and Glucose Homeostasis in Male Rats L Jessen, EP Smith, Y Ulrich-Lai, JP Herman, RJ Seeley, D Sandoval, D DAlessio	Endocrinology	2017
DPP-4 inhibitors and heart failure: a potential role for pharmacogenomics C Krittanawong, A Xanthopoulos, T Kitai, N Branis, HJ Zhang, M Kukin	Heart Failure Reviews	2017
The autonomic nervous system and cardiac GLP-1 receptors control heart rate in mice LL Baggio, JR Ussher, BA McLean, X Cao, MG Kabir, EE Mulvihill, AS Mighiu, H Zhang, A Ludwig, RJ Seeley, SP Heximer, DJ Drucker	Molecular Metabolism	2017
Gastrointestinal–Renal Axis: Role in the Regulation of Blood Pressure J Yang, PA Jose, C Zeng	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease	2017
Uncertainties around incretin-based therapies: A literature review BA Tulaihi, S Alhabib	Saudi Pharmaceutical Journal	2017
Gastric myoelectric activity during cisplatin-induced acute and delayed emesis reveals a temporal impairment of slow waves in ferrets: effects not reversed by the GLP-1 receptor antagonist, exendin (9-39) Z Lu, MP Ngan, G Lin, DT Yew, X Fan, PL Andrews, JA Rudd	Oncotarget	2017
Brain metabolic sensing and metabolic signaling at the level of an astrocyte N Marina, E Turovsky, IN Christie, PS Hosford, A Hadjihambi, A Korsak, R Ang, S Mastitskaya, S Sheikhbahaei, SM Theparambil, AV Gourine	Glia	2017
Does endogenous GLP-1 affect resting energy expenditure and fuel selection in overweight and obese adults? Poggiogalle E, Donini LM, Chiesa C, Pacifico L, Lenzi A, Perna S, Faliva M, Naso M, Rondanelli M	Journal of Endocrinological Investigation	2017
Disruption of Glucagon-Like Peptide 1 Signaling in Sim1 Neurons Reduces Physiological and Behavioral Reactivity to Acute and Chronic Stress Ghosal S, Packard AE, Mahbod P, McKlveen JM, Seeley RJ, Myers B, Ulrich-Lai Y, Smith EP, D'Alessio DA, Herman JP	Journal of Neuroscience	2017
Glucosensing in the gastrointestinal tract: Impact on glucose metabolism A Fournel, A Marlin, A Abot, C Pasquio, C Cirillo, PD Cani, C Knauf	AJP Gastrointestinal and Liver Physiology	2016
Cardiometabolic crosstalk in obesity-associated arterial hypertension J Jordan, AL Birkenfeld	Reviews in Endocrine and Metabolic Disorders	2016
Limiting glucocorticoid secretion increases the anorexigenic property of Exendin-4 SJ Lee, K Diener, S Kaufman, JP Krieger, KG Pettersen, N Jejelava, M Arnold, AG Watts, W Langhans	Molecular Metabolism	2016
Neural effects of gut- and brain-derived glucagon-like peptide-1 and its receptor agonist K Katsurada, T Yada	Journal of Diabetes Investigation	2016
Metabolically-inactive glucagon-like peptide-1(9–36)amide confers selective protective actions against post-myocardial infarction remodelling E Robinson, M Tate, S Lockhart, C McPeake, KM ONeill, KS Edgar, D Calderwood, BD Green, BJ McDermott, DJ Grieve	Cardiovascular Diabetology	2016
Exenatide acutely increases heart rate in parallel with augmented sympathetic nervous system activation in healthy overweight males: Exenatide-induced heart rate acceleration MM Smits, MH Muskiet, L Tonneijck, T Hoekstra, MH Kramer, M Diamant, DH van Raalte	British Journal of Clinical Pharmacology	2016
GLP-1 Agonists and Blood Pressure: A Review of the Evidence A Goud, J Zhong, M Peters, RD Brook, S Rajagopalan	Current Hypertension Reports	2016
Examining EXAMINE for an Interaction With Angiotensin-Converting Enzyme Inhibition JR Wilson, NJ Brown	Hypertension	2016
Exendin-4 induces myocardial protection through MKK3 and Akt-1 in infarcted hearts J Du, L Zhang, Z Wang, N Yano, YT Zhao, L Wei, P Dubielecka-Szczerba, PY Liu, S Zhuang, G Qin, TC Zhao	American journal of physiology. Cell physiology	2016
The physiological role of the brain GLP-1 system in stress MK Holt, S Trapp, W Wisden	Cogent Biology	2016
SF-1 expression in the hypothalamus is required for beneficial metabolic effects of exercise: ( A ) Distance run during an endurance capacity test in mice lacking SF-1 only in the VMH (VMH ∆SF-1 ) and control mice (age = 12–16 weeks). ( B ) Heart rate, ( C ) left ventricle end-diastolic diameters (LVEDD), and ( D ) left ventricle end-systolic diameters (LVESD) was determined by echocardiography (age = 20–28 weeks) in sedentary VMH ∆SF-1 and control mice. Oxygen-consumption rates (OCRs) in mitochondria isolated from TA muscle, in response to sequential ( E ) succinate- and ( F ) ADP-stimulation, were used for mitochondrial respiratory function (n = 5; age = 12–16 weeks). ( G ) Free fatty acid levels in the plasma in sedentary mice, and ( H ) after a single exercise (n = 8–11). Plasma was collected immediately after the exercise session (15 m/min for 60 min). Mice were fed with chow diet. Values are mean ± S.E.M. **p<0.0001, p<0.001, p<0.01, p<0.05 T Fujikawa, CM Castorena, M Pearson, CM Kusminski, N Ahmed, PK Battiprolu, KW Kim, S Lee, JA Hill, PE Scherer, WL Holland, JK Elmquist	eLife	2016
The Hypothalamic Glucagon-Like Peptide 1 Receptor Is Sufficient but Not Necessary for the Regulation of Energy Balance and Glucose Homeostasis in Mice MA Burmeister, JE Ayala, H Smouse, A Landivar-Rocha, JD Brown, DJ Drucker, DA Stoffers, DA Sandoval, RJ Seeley, JE Ayala	Diabetes	2016
Roux-en-Y gastric bypass: effects on feeding behaviour and underlying mechanisms Sean Manning, Andrea Pucci, Rachel Batterham	Journal of Clinical Investigation	2015
Neural Control of Energy Balance: Translating Circuits to Therapies L Gautron, JK Elmquist, KW Williams	Cell	2015
Effect of dipeptidyl peptidase-4 inhibition on circadian blood pressure during the development of salt-dependent hypertension in rats A Sufiun, K Rafiq, Y Fujisawa, A Rahman, H Mori, D Nakano, H Kobori, K Ohmori, T Masaki, M Kohno, A Nishiyama	Hypertension Research	2015
Spinally projecting preproglucagon axons preferentially innervate sympathetic preganglionic neurons IJ Llewellyn-Smith, N Marina, RN Manton, F Reimann, FM Gribble, S Trapp	Neuroscience	2015
Exendin-4 protects against post-myocardial infarction remodelling via specific actions on inflammation and the extracellular matrix E Robinson, RS Cassidy, M Tate, Y Zhao, S Lockhart, D Calderwood, R Church, MK McGahon, DP Brazil, BJ McDermott, BD Green, DJ Grieve	Basic Research in Cardiology	2015
Expression and Distribution of Glucagon-Like Peptide-1 Receptor mRNA, Protein and Binding in the Male Nonhuman Primate ( Macaca mulatta ) Brain KM Heppner, M Kirigiti, A Secher, SJ Paulsen, R Buckingham, C Pyke, LB Knudsen, N Vrang, KL Grove	Endocrinology	2015
Effects of Exenatide on Measures of Diabetic Neuropathy in Subjects with Type 2 Diabetes: Results from an 18-Month Proof-of-Concept Open Label Randomized Study M Jaiswal, CL Martin, MB Brown, B Callaghan, JW Albers, EL Feldman, R Pop-Busui	Journal of Diabetes and its Complications	2015
Effects of exogenous glucagon-like peptide-1 on blood pressure, heart rate, gastric emptying, mesenteric blood flow and glycaemic responses to oral glucose in older individuals with normal glucose tolerance or type 2 diabetes LG Trahair, M Horowitz, JE Stevens, C Feinle-Bisset, S Standfield, D Piscitelli, CK Rayner, AM Deane, KL Jones	Diabetologia	2015
Negative Energy Balance Blocks Neural and Behavioral Responses to Acute Stress by "Silencing" Central Glucagon-Like Peptide 1 Signaling in Rats JW Maniscalco, H Zheng, PJ Gordon, L Rinaman	The Journal of neuroscience : the official journal of the Society for Neuroscience	2015
Distribution and characterisation of Glucagon-like peptide-1 receptor expressing cells in the mouse brain SC Cork, JE Richards, MK Holt, FM Gribble, F Reimann, S Trapp	Molecular Metabolism	2015
The effects of GLP-1 analogues in obese, insulin-using type 2 diabetes in relation to eating behaviour SA de Boer, JD Lefrandt, JF Petersen, HH Boersma, DJ Mulder, K Hoogenberg	International Journal of Clinical Pharmacy	2015
PPG neurons of the lower brain stem and their role in brain GLP-1 receptor activation S Trapp, SC Cork	American Journal of Physiology - Regulatory, Integrative and Comparative Physiology	2015
CNS GLP-1R mediate anorectic, not glucose-lowering, effects of liraglutide Stephanie Sisley, RUTH GUTIERREZ-AGUILAR, Michael M. Scott, David D'Alessio, Darleen Sandoval, Randy Seeley	Journal of Clinical Investigation	2014
Liraglutide lowers body weight through regulation of CART, NPY, AGRP Anna Secher, Jacob Jelsing, Arian B Gonzalez, Jacob Hecksher-Sørensen, Michael Cowley, Louise Dalbøge, Gitte Hansen, Kevin Grove, Charles Pyke, Kirsten Raun, Lauge Schäffer, Mads Tang-Christensen, Saurabh Verma, Brent Witgen, Niels Vrang, Lotte Bjerre Knudsen	Journal of Clinical Investigation	2014
Gene-Environment Interactions Controlling Energy and Glucose Homeostasis and the Developmental Origins of Obesity S Bouret, BE Levin, SE Ozanne	Physiological reviews	2014
Heart Failure and Loss of Metabolic Control: ZV Wang, DL Li, JA Hill	Journal of Cardiovascular Pharmacology	2014
Molecular mechanisms underlying physiological and receptor pleiotropic effects mediated by GLP-1R activation: Molecular physiology of GLP-1R K Pabreja, MA Mohd, C Koole, D Wootten, SG Furness	British Journal of Pharmacology	2014
Neuroendocrine Circuits Governing Energy Balance and Stress Regulation: Functional Overlap and Therapeutic Implications YM Ulrich-Lai, KK Ryan	Cell Metabolism	2014
Positron emission tomography imaging of the glucagon-like peptide-1 receptor in healthy and streptozotocin-induced diabetic pigs L Nalin, RK Selvaraju, I Velikyan, M Berglund, S Andréasson, A Wikstrand, A Rydén, M Lubberink, F Kandeel, G Nyman, O Korsgren, O Eriksson, M Jensen-Waern	European Journal of Nuclear Medicine and Molecular Imaging	2014
GLP-1R activation for the treatment of stroke: Updating and future perspectives V Darsalia, D Nathanson, T Nyström, T Klein, Å Sjöholm, C Patrone	Reviews in Endocrine and Metabolic Disorders	2014
Inactivation of the cardiomyocyte glucagon-like peptide-1 receptor (GLP-1R) unmasks cardiomyocyte-independent GLP-1R-mediated cardioprotection JR Ussher, LL Baggio, JE Campbell, EE Mulvihill, M Kim, MG Kabir, X Cao, J Baranek, DA Stoffers, RJ Seeley, DJ Drucker	Molecular Metabolism	2014
Cardiovascular Actions of GLP-1 and Incretin-Based Pharmacotherapy A Avogaro, SV de Kreutzenberg, GP Fadini	Current Diabetes Reports	2014
Cardiovascular and hemodynamic effects of glucagon-like peptide-1 AG Goodwill, KJ Mather, AM Conteh, DJ Sassoon, JN Noblet, JD Tune	Reviews in Endocrine and Metabolic Disorders	2014
Glucagon-like peptide-1 (7-36) but not (9-36) augments cardiac output during myocardial ischemia via a Frank-Starling mechanism AG Goodwill, JD Tune, JN Noblet, AM Conteh, D Sassoon, ED Casalini, KJ Mather	Archiv für Kreislaufforschung	2014
GLP-1: benefits beyond pancreas G Muscogiuri, A Cignarelli, F Giorgino, F Prodram, D Santi, G Tirabassi, G Balercia, R Modica, A Faggiano, A Colao	Journal of Endocrinological Investigation	2014
Exendin-4 ameliorates cardiac ischemia/reperfusion injury via caveolae and caveolins-3 YM Tsutsumi, R Tsutsumi, E Hamaguchi, Y Sakai, A Kasai, Y Ishikawa, U Yokoyama, K Tanaka	Cardiovascular Diabetology	2014
GLP-1 (7–36) amide restores myocardial insulin sensitivity and prevents the progression of heart failure in senescent beagles M Chen, FS Angeli, Y Shen, RP Shannon	Cardiovascular Diabetology	2014
Dipeptidyl-Peptidase 4 Inhibition and the Vascular Effects of Glucagon-like Peptide-1 and Brain Natriuretic Peptide in the Human Forearm JK Devin, M Pretorius, H Nian, C Yu, FT Billings, NJ Brown	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease	2014
Progesterone Receptor Membrane Component 1 Is a Functional Part of the Glucagon-like Peptide-1 (GLP-1) Receptor Complex in Pancreatic Cells M Zhang, M Robitaille, AD Showalter, X Huang, Y Liu, A Bhattacharjee, FS Willard, J Han, S Froese, L Wei, HY Gaisano, S Angers, KW Sloop, FF Dai, MB Wheeler	Molecular & cellular proteomics : MCP	2014
Endogenous Glucagon-Like Peptide-1 Reduces Drinking Behavior and Is Differentially Engaged by Water and Food Intakes in Rats NJ McKay, DL Galante, D Daniels	The Journal of neuroscience : the official journal of the Society for Neuroscience	2014
Stimulation of glucagon-like peptide-1 receptor through exendin-4 preserves myocardial performance and prevents cardiac remodeling in infarcted myocardium M DeNicola, J Du, Z Wang, N Yano, L Zhang, Y Wang, G Qin, S Zhuang, TC Zhao	American journal of physiology. Endocrinology and metabolism	2014
Long Term Exendin-4 Treatment Reduces Food Intake and Body Weight and Alters Expression of Brain Homeostatic and Reward Markers Y Yang, AA Moghadam, ZA Cordner, NC Liang, TH Moran	Endocrinology	2014
Substance P Increases Sympathetic Activity During Combined Angiotensin-Converting Enzyme and Dipeptidyl Peptidase-4 Inhibition JK Devin, M Pretorius, H Nian, C Yu, FT Billings, NJ Brown	Hypertension	2014
GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure M Kim, MJ Platt, T Shibasaki, SE Quaggin, PH Backx, S Seino, JA Simpson, DJ Drucker	Nature Medicine	2013
Beyond glycemic control in diabetes mellitus: effects of incretin-based therapies on bone metabolism E Ceccarelli, EG Guarino, D Merlotti, A Patti, L Gennari, R Nuti, F Dotta	Frontiers in Endocrinology	2013
The gut hormone glucagon-like peptide-1 produced in brain: is this physiologically relevant? S Trapp, JE Richards	Current Opinion in Pharmacology	2013
Role of central glucagon-like peptide-1 in stress regulation S Ghosal, B Myers, JP Herman	Physiology & Behavior	2013
Direct cardiovascular effects of glucagon like peptide-1 A Sheikh	Diabetology & metabolic syndrome	2013
Glucagon-like peptide-1 (GLP-1) and protective effects in cardiovascular disease: a new therapeutic approach for myocardial protection TC Zhao	Cardiovascular Diabetology	2013
Peptide and lipid modulation of glutamatergic afferent synaptic transmission in the solitary tract nucleus MC Andresen, JA Fawley, ME Hofmann	Frontiers in neuroscience	2013
Elevated blood pressure, heart rate and body temperature in mice lacking the XLαs protein of the Gnas locus is due to increased sympathetic tone: Sympathetic cardiovascular stimulation in Gnasxl knock-out mice N Nunn, CH Feetham, J Martin, R Barrett-Jolley, A Plagge	Experimental Physiology	2013
Glucagon-Like Peptide-1 Receptor Agonist Administration Suppresses Both Water and Saline Intake in Rats NJ McKay, D Daniels	Journal of Neuroendocrinology	2013
Preproglucagon (PPG) neurons innervate neurochemicallyidentified autonomic neurons in the mouse brainstem IJ Llewellyn-Smith, GJ Gnanamanickam, F Reimann, FM Gribble, S Trapp	Neuroscience	2013
Insulin- and glucagon-like peptide-1-induced changes in heart rate and vagosympathetic activity: why they matter P Valensi, S Chiheb, M Fysekidis	Diabetologia	2013
Cardiovascular effects of antidiabetic agents: focus on blood pressure effects of incretin-based therapies NJ Brown	Journal of the American Society of Hypertension	2012
Glucagon-Like Peptide-1 and its Cardiovascular Effects KS Heo, K Fujiwara, J Abe	Current Atherosclerosis Reports	2012
Exendin-4 decreases amphetamine-induced locomotor activity K Erreger, AR Davis, AM Poe, NH Greig, GD Stanwood, A Galli	Physiology & Behavior	2012
Cardiovascular Biology of the Incretin System JR Ussher, DJ Drucker	Endocrine reviews	2012
A VGF-Derived Peptide Attenuates Development of Type 2 Diabetes via Enhancement of Islet β-Cell Survival and Function SB Stephens, JC Schisler, HE Hohmeier, J An, AY Sun, GS Pitt, CB Newgard	Cell Metabolism	2012
Methods in Enzymology FX Choong, RM Sandoval, BA Molitoris, A Richter-Dahlfors	Methods in enzymology	2012
Effects of intravenous exenatide in type 2 diabetic patients with congestive heart failure: a double-blind, randomised controlled clinical trial of efficacy and safety D Nathanson, B Ullman, U Löfström, A Hedman, M Frick, Å Sjöholm, T Nyström	Diabetologia	2012
The effect of glucagon-like peptide 1 on cardiovascular risk J Sivertsen, J Rosenmeier, JJ Holst, T Vilsbøll	Nature Reviews Cardiology	2012
Kardiovaskuläre Effekte inkretinbasierter Therapien M Lehrke, N Marx	Herz	2012
Glucagon-like peptide-1 receptor agonist protects against hyperglycemia-induced cardiocytes injury by inhibiting high mobility group box 1 expression Y Cai, X Hu, B Yi, T Zhang, Z Wen	Molecular Biology Reports	2012
Role of intestinal peptides and the autonomic nervous system in postprandial hypotension in patients with multiple system atrophy T Fukushima, M Asahina, Y Fujinuma, Y Yamanaka, A Katagiri, M Mori, S Kuwabara	Journal of Neurology	2012
Pancreatic GLP-1 receptor activation is sufficient for GLP-1R-dependent control of glucose metabolism in mice Benjamin Lamont, Yazhou Li, Edwin Kwan, Ted Brown, Herbert Gaisano, Daniel J. Drucker	Journal of Clinical Investigation	2011
Hypothalamic control of energy and glucose metabolism S Sisley, D Sandoval	Reviews in Endocrine and Metabolic Disorders	2011
GLP-1 and energy balance: an integrated model of short-term and long-term control JG Barrera, DA Sandoval, DA D'Alessio, RJ Seeley	Nature Reviews Endocrinology	2011
Is the GLP-1 system a viable therapeutic target for weight reduction? J Tong, DA Sandoval	Reviews in endocrine & metabolic disorders	2011
GLP-1, the gut-brain, and brain-periphery axes C Cabou, R Burcelin	The review of diabetic studies : RDS	2011
Multifactorial intervention in Type 2 diabetes: The promise of incretin-based therapies F Giorgino, A Leonardini, A Natalicchio, L Laviola	Journal of Endocrinological Investigation	2011
Cardiovascular effects of incretin-based therapies M Lehrke, N Marx	The review of diabetic studies : RDS	2011
Glucagon-like peptide-1 receptor agonists suppress water intake independent of effects on food intake NJ McKay, SE Kanoski, MR Hayes, D Daniels	American Journal of Physiology - Regulatory, Integrative and Comparative Physiology	2011
Brain GLP-1 Signaling Regulates Femoral Artery Blood Flow and Insulin Sensitivity Through Hypothalamic PKC- C Cabou, C Vachoux, G Campistron, DJ Drucker, R Burcelin	Diabetes	2011
Beneficial Effects of Exendin-4 on Experimental Polyneuropathy in Diabetic Mice T Himeno, H Kamiya, K Naruse, N Harada, N Ozaki, Y Seino, T Shibata, M Kondo, J Kato, T Okawa, A Fukami, Y Hamada, N Inagaki, Y Seino, DJ Drucker, Y Oiso, J Nakamura	Diabetes	2011
Both stimulation of GLP-1 receptors and inhibition of glycogenolysis additively contribute to a protective effect of oral miglitol against ischaemia-reperfusion injury in rabbits: Miglitol and GLP-1 receptors M Iwasa, Y Yamada, H Kobayashi, S Yasuda, I Kawamura, S Sumi, T Shiraki, T Yamaki, H Ushikoshi, A Hattori, T Aoyama, K Nishigaki, G Takemura, H Fujiwara, S Minatoguchi	British Journal of Pharmacology	2011
Understanding the Cardiovascular Effects of Incretin JS Yoon, HW Lee	Diabetes & Metabolism Journal	2011
Lipid-Induced Peroxidation in the Intestine Is Involved in Glucose Homeostasis Imbalance in Mice M Serino, A Waget, N Marsollier, M Masseboeuf, G Payros, C Kabani, J Denom, A Lacombe, JC Thiers, A Negre-Salvayre, S Luquet, R Burcelin, C Cruciani-Guglielmacci, C Magnan, L Brennan	PloS one	2011
The Thyrotropin-Releasing Hormone Gene Is Regulated by Thyroid Hormone at the Level of Transcription in Vivo ML Sugrue, KR Vella, C Morales, ME Lopez, AN Hollenberg	Endocrinology	2010
Leptin and the systems neuroscience of meal size control HJ Grill	Frontiers in Neuroendocrinology	2010
Potential role of TCF7L2 gene variants on cardiac sympathetic/parasympathetic activity V Boccardi, I Ambrosino, M Papa, D Fiore, MR Rizzo, G Paolisso, M Barbieri	European Journal of Human Genetics	2010
Exendin-4 increases blood glucose levels acutely in rats by activation of the sympathetic nervous system D Pérez-Tilve, L González-Matías, BA Aulinger, M Alvarez-Crespo, M Gil-Lozano, E Alvarez, AM Andrade-Olivie, MH Tschöp, DA D'Alessio, F Mallo	American journal of physiology. Endocrinology and metabolism	2010
Preclinical and Clinical Data on Extraglycemic Effects of GLP-1 Receptor Agonists B Gallwitz	The review of diabetic studies : RDS	2010
Role of the glucagon-like-peptide-1 receptor in the control of energy balance MR Hayes, BC de Jonghe, SE Kanoski	Physiology & Behavior	2010
Role of glucocorticoids in tuning hindbrain stress integration R Zhang, R Jankord, JN Flak, MB Solomon, DA D'Alessio, JP Herman	The Journal of neuroscience : the official journal of the Society for Neuroscience	2010
Effect of exenatide on heart rate and blood pressure in subjects with type 2 diabetes mellitus: a double-blind, placebo-controlled, randomized pilot study A Gill, BJ Hoogwerf, J Burger, S Bruce, L Macconell, P Yan, D Braun, J Giaconia, J Malone	Cardiovascular Diabetology	2010
Inkretine: Gibt es kardiovaskuläre Effekte? B Gallwitz	Herz	2010
GLP-1 receptor stimulation depresses heart rate variability and inhibits neurotransmission to cardiac vagal neurons KJ Griffioen, R Wan, E Okun, X Wang, MR Lovett-Barr, Y Li, MR Mughal, D Mendelowitz, MP Mattson	Cardiovascular Research	2010
Possible involvement of GLP-1(9-36) in the regional haemodynamic effects of GLP-1(7-36) in conscious rats: Cardiovascular effects of GLP-1(7-36) SM Gardiner, JE March, PA Kemp, T Bennett, DJ Baker	British Journal of Pharmacology	2010
The Cardiovascular Effects of GLP-1 Receptor Agonists: The Cardiovascular Effects of GLP-1 Receptor Agonists T Okerson, RJ Chilton	Cardiovascular Therapeutics	2010
The incretin system and cardiometabolic disease. Szmitko PE, Leiter LA, Verma S	The Canadian journal of cardiology	2010
Pulmonary surfactant: an immunological perspective ZC Chroneos, Z Sever-Chroneos, VL Shepherd	Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology	2009
Emerging cardiovascular actions of the incretin hormone glucagon-like peptide-1: potential therapeutic benefits beyond glycaemic control? DJ Grieve, RS Cassidy, BD Green	British Journal of Pharmacology	2009
Differences in the central anorectic effects of glucagon-like peptide-1 and exendin-4 in rats JG Barrera, DA D'Alessio, DJ Drucker, SC Woods, RJ Seeley	Diabetes	2009
Hindbrain cocaine- and amphetamine-regulated transcript induces hypothermia mediated by GLP-1 receptors KP Skibicka, AL Alhadeff, HJ Grill	The Journal of neuroscience : the official journal of the Society for Neuroscience	2009
GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice MH Noyan-Ashraf, MA Momen, K Ban, AM Sadi, YQ Zhou, AM Riazi, LL Baggio, RM Henkelman, M Husain, DJ Drucker	Diabetes	2009
Expression of the diabetes-associated geneTCF7L2in adult mouse brain S Lee, CE Lee, CF Elias, JK Elmquist	The Journal of Comparative Neurology	2009
Single Dose GLP-1-Tf Ameliorates Myocardial Ischemia/Reperfusion Injury M Matsubara, S Kanemoto, BG Leshnower, EF Albone, R Hinmon, T Plappert, JH 3rd, RC Gorman	The Journal of surgical research	2009
The Extrapancreatic Effects of Glucagon-Like Peptide-1 and Related Peptides R Abu-Hamdah, A Rabiee, GS Meneilly, RP Shannon, DK Andersen, D Elahi	The Journal of clinical endocrinology and metabolism	2009
Direct control of peripheral lipid deposition by CNS GLP-1 receptor signaling is mediated by the sympathetic nervous system and blunted in diet-induced obesity R Nogueiras, D Pérez-Tilve, C Veyrat-Durebex, DA Morgan, L Varela, WG Haynes, JT Patterson, E Disse, PT Pfluger, M López, SC Woods, R DiMarchi, C Diéguez, K Rahmouni, F Rohner-Jeanrenaud, MH Tschöp	The Journal of neuroscience : the official journal of the Society for Neuroscience	2009
The role of incretins in cardiovascular control. Mafong DD, Henry RR	Current Hypertension Reports	2009
Arcuate glucagon-like peptide 1 receptors regulate glucose homeostasis but not food intake DA Sandoval, D Bagnol, SC Woods, DA D'Alessio, RJ Seeley	Diabetes	2008
CNS GLP-1 regulation of peripheral glucose homeostasis D Sandoval	Physiology & Behavior	2008
Transplantation of PC1/3-Expressing α-cells Improves Glucose Handling and Cold Tolerance in Leptin-resistant Mice RD Wideman, SL Gray, SD Covey, GC Webb, TJ Kieffer	Molecular Therapy	2008
Effects of glucagon-like peptide-1, yohimbine, and nitrergic modulation on sympathetic and parasympathetic activity in humans AE Bharucha, N Charkoudian, CN Andrews, M Camilleri, D Sletten, AR Zinsmeister, PA Low	American Journal of Physiology - Regulatory, Integrative and Comparative Physiology	2008
Caudal brainstem processing is sufficient for behavioral, sympathetic, and parasympathetic responses driven by peripheral and hindbrain glucagon-like-peptide-1 receptor stimulation MR Hayes, KP Skibicka, HJ Grill	Endocrinology	2008
Brain Glucagon-Like Peptide-1 Regulates Arterial Blood Flow, Heart Rate, and Insulin Sensitivity C Cabou, G Campistron, N Marsollier, C Leloup, C Cruciani-Guglielmacci, L Penicaud, DJ Drucker, C Magnan, R Burcelin	Diabetes	2008
Role of Central Nervous System Glucagon-Like Peptide-1 Receptors in Enteric Glucose Sensing C Knauf, PD Cani, DH Kim, MA Iglesias, C Chabo, A Waget, A Colom, S Rastrelli, NM Delzenne, DJ Drucker, RJ Seeley, R Burcelin	Diabetes	2008
Autonomic nervous system-dependent and -independent cardiovascular effects of exendin-4 infusion in conscious rats SM Gardiner, JE March, PA Kemp, T Bennett	British Journal of Pharmacology	2008
Role of central glucagon-like peptide-1 in hypothalamo-pituitary-adrenocortical facilitation following chronic stress M Tauchi, R Zhang, DA D'Alessio, RJ Seeley, JP Herman	Experimental Neurology	2008
Distribution of glucagon-like peptide-1 immunoreactivity in the hypothalamic paraventricular and supraoptic nuclei M Tauchi, R Zhang, DA D’Alessio, JE Stern, JP Herman	Journal of Chemical Neuroanatomy	2008
The Role of Incretins in Glucose Homeostasis and Diabetes Treatment W Kim, JM Egan	Pharmacological reviews	2008
Gastrointestinal Regulation of Food Intake David E. Cummings, MD and Joost Overduin, PhD	Journal of Clinical Investigation	2007
Effects of glucagon-like peptide-1 and sympathetic stimulation on gastric accommodation in humans CN Andrews, AE Bharucha, M Camilleri, PA Low, BM Seide, DD Burton, KK Nickander, KL Baxter, AR Zinsmeister	Neurogastroenterology & Motility	2007
Transient Receptor Potential Vanilloid 1 Antagonist, Capsazepine, Improves Survival in a Rat Hemorrhagic Shock Model H Akabori, H Yamamoto, H Tsuchihashi, T Mori, K Fujino, T Shimizu, Y Endo, T Tani	Annals of Surgery	2007
Incretins: clinical physiology and bariatric surgery--correlating the entero-endocrine system and a potentially anti-dysmetabolic procedure. Lamounier RN, Pareja JC, Tambascia MA, Geloneze B	Obesity surgery	2007
Gastrointestinal hormones regulating appetite O Chaudhri, C Small, S Bloom	Philosophical Transactions of the Royal Society B: Biological Sciences	2006
Gut hormones ghrelin, PYY, and GLP-1 in the regulation of energy balance [corrected] and metabolism. Perez-Tilve D, Nogueiras R, Mallo F, Benoit SC, Tschoep M	Endocrine	2006
Exendin-4, but not glucagon-like peptide-1, is cleared exclusively by glomerular filtration in anaesthetised pigs. Simonsen L, Holst JJ, Deacon CF	Diabetologia	2006
Brain Glucagon-Like Peptide-One increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage Claude Knauf, Patrice D. Cani, Christophe Perrin, Miguel A. Iglesias, Jean François Maury, Elodie Bernard, Fadilha Benhamed, Thierry Grémeaux, Daniel J. Drucker, C. Ronald Kahn, Jean Girard, Jean François Tanti, Nathalie M Delzenne, Catherine Postic, Rémy Burcelin	Journal of Clinical Investigation	2005
A Possible Role of GLP-1 in the Pathophysiology of Early Dumping Syndrome H Yamamoto, T Mori, H Tsuchihashi, H Akabori, H Naito, T Tani	Digestive Diseases and Sciences	2005
New ways in which GLP-1 can regulate glucose homeostasis DA D'Alessio, DA Sandoval, RJ Seeley	Journal of Clinical Investigation	2005
Class II G protein-coupled receptors and their ligands in neuronal function and protection. Martin B, Lopez de Maturana R, Brenneman R, Walent T, Mattson MP, Maudsley S	NeuroMolecular Medicine	2005
Race affects insulin and GLP-1 secretion and response to a long-acting somatostatin analogue in obese adults PA Velasquez-Mieyer, GE Umpierrez, RH Lustig, AK Cashion, PA Cowan, M Christensen, KA Spencer, GA Burghen	International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity	2004
Glucagon-like peptide 1 excites hypocretin/orexin neurons by direct and indirect mechanisms: implications for viscera-mediated arousal. Acuna-Goycolea C, van den Pol A	The Journal of neuroscience : the official journal of the Society for Neuroscience	2004
Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice Hiroaki Masuzaki, Hiroshi Yamamoto, Christopher J Kenyon, Joel K Elmquist, Nicholas M Morton, Janice M Paterson, Hiroshi Shinyama, Matthew GF Sharp, Stewart Fleming, John J Mullins, Jonathan R Seckl, Jeffrey S Flier	Journal of Clinical Investigation	2003
Glucagon-Like Peptide-1-Responsive Catecholamine Neurons in the Area Postrema Link Peripheral Glucagon-Like Peptide-1 with Central Autonomic Control Sites Yamamoto H, Kishi T, Lee CE, Choi BJ, Fang H, Hollenberg AN, Drucker DJ, Elmquist JK	Journal of Neuroscience	2003
CNS Glucagon-Like Peptide-1 Receptors Mediate Endocrine and Anxiety Responses to Interoceptive and Psychogenic Stressors Kinzig KP, D'Alessio DA, Herman JP, Sakai RR, Vahl TP, Figueiredo HF, Murphy EK, Seeley RJ	Journal of Neuroscience	2003

Advertisement